International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.25% | -6.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.25% | -6.52% | |||
| Cost of Revenue | 1.64% | 6.68% | |||
| Gross Profit | 20.83% | -15.02% | |||
| SG&A Expenses | 47.74% | -11.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.55% | 3.99% | |||
| Operating Income | 156.67% | -160.40% | |||
| Income Before Tax | 108.80% | -205.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 108.80% | -205.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 108.80% | -205.04% | |||
| EBIT | 156.67% | -160.40% | |||
| EBITDA | 383.78% | -118.59% | |||
| EPS Basic | 108.97% | -302.60% | |||
| Normalized Basic EPS | 109.18% | -205.38% | |||
| EPS Diluted | 108.97% | -302.60% | |||
| Normalized Diluted EPS | 109.18% | -205.38% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||